RXRX250103P11000
- 0.00
- 0.000.00%
Recursion Pharmaceuticals Newsroom
Recursion to Present at 43rd Annual JP Morgan Healthcare Conference
Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Trending Industry Today: Serve Robotics Leads Gains In NVIDIA Portfolio Stocks
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
Trending Industry Today: Nano X Imaging Leads Gains In NVIDIA Portfolio Stocks
Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) 30% Share Price Surge Not Quite Adding Up
Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment
Trending Industry Today: Arm Holdings Leads Losses In NVIDIA Portfolio Stocks
Is Recursion Pharmaceuticals Stock a Millionaire Maker?
Express News | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Trending Industry Today: Applied Digital Leads Gains Pre-Market In NVIDIA Portfolio Stocks
Trending Industry Today: Serve Robotics Leads Losses In NVIDIA Portfolio Stocks
Express News | Recursion Pharmaceuticals Inc - Registering for Resale 3.5 Mln Shares of Class a Common Stock
Express News | Recursion Pharmaceuticals Inc - Files Prospectus Supplement
Trending Industry Today: SoundHound AI Leads Losses In NVIDIA Portfolio Stocks
Jim Cramer Says He Was Wrong on NVIDIA Holding Recursion Pharmaceuticals (RXRX)
Trending Industry Today: SoundHound AI Leads Gains In NVIDIA Portfolio Stocks
Trending Industry Today: Applied Digital Leads Gains In NVIDIA Portfolio Stocks
Recursion Pharmaceuticals' (RXRX) AI-Driven Cancer Treatment Shows Promise in Early Trials